Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERIFY: Durability of Vildagliptin + Metformin vs Metformin in T2DM
NCT01528254Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Mar 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01528254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528254.